Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland; Department of Physical Chemistry and Electrochemistry, Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Krakow, Poland.
Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
Int J Pharm. 2017 Nov 30;533(2):470-479. doi: 10.1016/j.ijpharm.2017.03.078. Epub 2017 Mar 29.
Dissolution of bicalutamide processed with polyvinylpyrrolidone by either supercritical carbon dioxide or ball milling has been investigated. Various compositions as well as process parameters were used to obtain binary systems of the drug with the carrier. Thermal analysis and powder X-ray diffractometry confirmed amorphization of bicalutamide mechanically activated by ball milling and the decrease in crystallinity of the supercritical carbon dioxide-treated drug. Both methods led to reduction of particles size what was confirmed by scanning electron microscopy and laser diffraction measurements. Moreover, the effect of micronisation was found to depend on the parameters of applied process. Fourier transform infrared spectroscopy revealed the appearance of intermolecular interactions between drug and carrier molecules that play an important role in the stabilization of amorphous form of the active compound. Changes in crystal structure combined with reduced size of particles of bicalutamide dispersed within polymer matrix were found to improve dissolution of bicalutamide by 4 to 10-fold in comparison to untreated drug. It is of particular importance as poor dissolution profiles are considered to be the major limitation in bioavailability of the drug.
采用超临界二氧化碳或球磨法对聚维酮处理的比卡鲁胺进行了溶解研究。使用各种组成和工艺参数来获得药物与载体的二元体系。热分析和粉末 X 射线衍射证实了球磨机械活化的比卡鲁胺的非晶化,以及超临界二氧化碳处理药物的结晶度降低。这两种方法都导致了粒径的减小,这通过扫描电子显微镜和激光衍射测量得到了证实。此外,发现微粉化的效果取决于所应用工艺的参数。傅里叶变换红外光谱揭示了药物和载体分子之间的分子间相互作用的出现,这些相互作用在稳定活性化合物的无定形形式中起着重要作用。晶体结构的变化以及分散在聚合物基质中的比卡鲁胺颗粒尺寸的减小,使得药物的溶解度提高了 4 至 10 倍,与未处理的药物相比。这一点尤其重要,因为较差的溶解曲线被认为是药物生物利用度的主要限制因素。